MRI of the heart for the assessment of structural and functional changes in the myocardium in patients with chronic heart failure.

Chronic heart failure (CHF) is a severe clinical syndrome, which can develop in patients with various heart diseases. Tactics of management of patients with CHF depends on cause of development of this syndrome, therefore exact diagnosis is especially important. Echocardiography (EchoCG) is the main method in algorithm of examination with any cardiological examination, but neither EchoCG, nor other traditional cardiological methods of examination in all clinical situations can reveal cause of development of CHF, therefore search for new diagnostic strategies is important. Objective of the work: to show possibilities of magnetic resonance tomography of heart in examination of patients with chronic heart failure on example of own clinical observations. Materials and methods. Analyzed heart studies performed on patients with chronic heart failure from March 2024 to December 2025. An analysis of the literature devoted to the diagnosis of chronic heart failure was conducted, and the search was carried out using the Google Scholar, Scopus, PubMed, and Web of Science databases. All clinical cases presented in the article were performed by the authors of the article. Results. Along with traditional methods of cardio-visualization (EchoCG, scintigraphy of myocardium), MRI with contrast agent is included in diagnostic algorithm of examination of patients with chronic heart failure, especially in complex situations. The article presents standard protocols of MRI for analysis of structural and functional changes of myocardium, contraindications to performance of MRI. On clinical observations possibilities of MRI are demonstrated in clarification of etiology of chronic heart failure in patients with reduced ejection fraction and preserved ejection fraction of left ventricle. Presented clinical cases of use of MRI for differential diagnosis of various causes of hypertrophy of myocardium of LV in patients with CHF, differential diagnosis of ischemic and non-ischemic lesion of myocardium. Conclusion. In the work are demonstrated the possibilities magnetic resonance tomography is highly informative method of diagnosis in patients with chronic heart failure, both in patients with reduced ejection fraction and in absence of its reduction.

1. Triposkiadis F., Butler J., Abboud F.M., et al. The continuous heart failure spectrum: Moving beyond an ejection fraction classification. European Heart Journal. 2019;40(26):2155–2163. https://doi.org/10.1093/eurheartj/ehz158

2. Keller M., Magunia H., Rosenberger P., Koeppen M. Echocardiography as a Tool to Assess Cardiac Function in Critical Care-A Review. Diagnostics (Basel, Switzerland). 2026;13(5):839. https://doi.org/10.3390/diagnostics13050839

3. Elmadi J, Satish Kumar L, Pugalenthi L, et al. Cardiovascular Magnetic Resonance Imaging: A Prospective Modality in the Diagnosis and Prognostication of Heart Failure. Cureus. 2022;14(4):e23840. https://doi.org/10.7759/cureus.23840

4. Стукалова О.В., Беляевская А.А., Терновой С.К. Оценка фракции выброса левого желудочка с помощью кино-МРТ без задержки дыхания и синхронизации с ЭКГ. REJR 2024;14(1):89-97. https://doi.org/10.21569/2222-7415-2024-14-1-89-97 [Stukalova O.V., Beliaevskaia A.A., Ternovoy S.K. Assessment of left ventricular ejection fraction using cine-MRI without breath-holding and synchronization with ECG. REJR 2024;14(1):89-97. (In Russ.) https://doi.org/10.21569/2222-7415-2024-14-1-89-97 ]

5. Soloff EV, Wang CL. Safety of Gadolinium-Based Contrast Agents in Patients with Stage 4 and 5 Chronic Kidney Disease: a Radiologist's Perspective. Kidney360. 2020 Jan 9;1(2):123-126. https://doi.org/10.34067/KID.0000502019

6. Barison A, Baritussio A, Cipriani A, De Lazzari M, Aquaro GD,Guaricci AI, Pica S, Pontone G, Todiere G, Indolfi C, Dellegrottaglie S; Working Group on Cardiac Magnetic Resonance of the Italian Society of Cardiology. Cardiovascular magnetic resonance: What clinicians should know about safety and contraindications. Int J Cardiol. 2021 May 15;331:322-328. https://doi.org/10.1016/j.ijcard.2021.02.003

7. Jiang M, Lu M, Zhao S. Cardiac Functional Assessment by Magnetic Resonance Imaging. Cardiol Discov. 2024 Dec;4(4):284-299. https://doi.org/10.1097/CD9.0000000000000141

8. Hahn RT, Lerakis S, Delgado V, Addetia K, Burkhoff D, Muraru D, Pinney S, Friedberg MK. Multimodality Imaging of Right Heart Function: JACC Scientific Statement. J Am Coll Cardiol. 2023 May 16;81(19):1954-1973. https://doi.org/10.1016/j.jacc.2023.03.392

9. Shams P, Malik A, Chhabra L. Heart Failure (Congestive Heart Failure). 2025 Feb 26. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 28613623. Available from https://www.ncbi.nlm.nih.gov/books/NBK430873/

10. Li XM, Jiang L, Min CY, Yan WF, Shen MT, Liu XJ, Guo YK, Yang ZG. Myocardial Perfusion Imaging by Cardiovascular Magnetic Resonance: Research Progress and Current Implementation. Curr Probl Cardiol. 2023 Jun;48(6):101665. https://doi.org/10.1016/j.cpcardiol.2023.101665

11. Patel AR, Salerno M, Kwong RY, Singh A, Heydari B, Kramer CM. Stress Cardiac Magnetic Resonance Myocardial Perfusion Imaging: JACC Review Topic of the Week. J Am Coll Cardiol. 2021 Oct 19;78(16):1655-1668. https://doi.org/10.1016/j.jacc.2021.08.022

12. Reynolds HR, Maehara A, Kwong RY, Sedlak T, Saw J, Smilowitz NR, Mahmud E, Wei J, Marzo K, Matsumura M, Seno A, Hausvater A, Giesler C, Jhalani N, Toma C, Har B, Thomas D, Mehta LS, Trost J, Mehta PK, Ahmed B, Bainey KR, Xia Y, Shah B, Attubato M, Bangalore S, Razzouk L, Ali ZA, Merz NB, Park K, Hada E, Zhong H, Hochman JS. Coronary Optical Coherence Tomography and Cardiac Magnetic Resonance Imaging to Determine Underlying Causes of Myocardial Infarction With Nonobstructive Coronary Arteries in Women. Circulation. 2021 Feb 16;143(7):624-640. doi: 10.1161/CIRCULATIONAHA.120.052008. Epub 2020 Nov 14. Erratum in: Circulation. 2023 Feb 21;147(8):e624. https://doi.org/10.1161/circulationaha.120.052008

13. Calvieri C, Riva A, Sturla F, Dominici L, Conia L, Gaudio C, Miraldi F, Secchi F, Galea N. Left Ventricular Adverse Remodeling in Ischemic Heart Disease: Emerging Cardiac Magnetic Resonance Imaging Biomarkers. J Clin Med. 2023 Jan 1;12(1):334. https://doi.org/10.3390/jcm12010334

14. Liu C, Ferrari VA, Han Y. Cardiovascular Magnetic Resonance Imaging and Heart Failure. Curr Cardiol Rep. 2021 Mar 8;23(4):35. https://doi.org/10.1007/s11886-021-01464-9

15. Schultheiss HP, Fairweather D, Caforio ALP, Escher F, Hershberger RE, Lipshultz SE, Liu PP, Matsumori A, Mazzanti A, McMurray J, Priori SG. Dilated cardiomyopathy. Nat Rev Dis Primers. 2019 May 9;5(1):32. https://doi.org/10.1038/s41572-019-0084-1

16. Lampejo T, Durkin SM, Bhatt N, Guttmann O. Acute myocarditis: aetiology, diagnosis and management. Clin Med (Lond). 2021 Sep;21(5):e505-e510. https://doi.org/10.7861/clinmed.2021-0121

17. Vidusa L, Kalejs O, Maca-Kaleja A, Strumfa I. Role of Endomyocardial Biopsy in Diagnostics of Myocarditis. Diagnostics (Basel). 2022 Aug 30;12(9):2104. https://doi.org/10.3390/diagnostics12092104

18. Khanna S, Amarasekera AT, Li C, Bhat A, Chen HHL, Gan GCH, Ugander M, Tan TC. The utility of cardiac magnetic resonance imaging in the diagnosis of adult patients with acute myocarditis: a systematic review and meta-analysis. Int J Cardiol. 2022 Sep 15;363:225-239. https://doi.org/10.1016/j.ijcard.2022.06.047

19. Coraducci F, De Zan G, Fedele D, Costantini P, Guaricci AI, Pavon AG, Teske A, Cramer MJ, Broekhuizen L, Van Osch D, Danad I, Velthuis B, Suchá D, van der Bilt I, Pizzi C, Russo AD, Oerlemans M, van Laake LW, van der Harst P, Guglielmo M. Cardiac magnetic resonance in advanced heart failure. Echocardiography. 2024 Jun;41(6):e15849. https://doi.org/10.1111/echo.15849

20. Authors/Task Force Members:; McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A; ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2022 Jan;24(1):4-131. https://doi.org/10.1002/ejhf.2333

21. Maron BJ, Desai MY, Nishimura RA, Spirito P, Rakowski H, Towbin JA, Rowin EJ, Maron MS, Sherrid MV. Diagnosis and Evaluation of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022 Feb 1;79(4):372-389. https://doi.org/10.1016/j.jacc.2021.12.002

22. Rowin EJ, Maron BJ, Maron MS. The Hypertrophic Cardiomyopathy Phenotype Viewed Through the Prism of Multimodality Imaging: Clinical and Etiologic Implications. JACC Cardiovasc Imaging. 2020 Sep;13(9):2002-2016. https://doi.org/10.1016/j.jcmg.2019.09.020

23. Aquaro GD, De Gori C, Faggioni L, Parisella ML, Aringhieri G, Cioni D, Lencioni R, Neri E. Cardiac Magnetic Resonance in Fabry Disease: Morphological, Functional, and Tissue Features. Diagnostics (Basel). 2022 Nov 1;12(11):2652. https://doi.org/10.3390/diagnostics12112652

24. Путило Д.В., Стукалова О.В., Шалагинова Ю.О., Матчина А.Ю., Сухинина Т.С. МРТ в диагностике острого инфаркта миокар да у пациентки с гипертрофической кардиомиопатией. REJR 2023;13(1):126-133. https://doi.org/10.21569/2222-7415-2023-13-1-126-133 [Putilo D.V., Stukalova O.V., Shalaginova Yu.O., Matchina A.Yu., Sukhinina T.S. MRI in diagnosis of acute myocardial infarction in a patient with hypertrophic cardiomyopathy. REJR 2023;13(1):126 133. (In Russ.) https://doi.org/10.21569/2222-7415-2023-13-1-126-133 ]

25. Cuddy SAM, Falk RH. Amyloidosis as a Systemic Disease in Context. Can J Cardiol. 2020 Mar;36(3):396-407. https://doi.org/10.1016/j.cjca.2019.12.033

26. Huang H, Liu Y, Chen X, Guo H, Yin Y, Ding M, Liu Y. Analysis and insights of cardiac amyloidosis: novel perception of rare diseases in cardiology. Am J Transl Res. 2024 Sep 15;16(9):4534-4548. https://doi.org/10.62347/KXHZ6884

27. Shams P, Goyal A, Makaryus AN. Left Ventricular Ejection Fraction. 2025 Jun 14. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 29083812. Available from: https://www.ncbi.nlm.nih.gov/books/NBK459131/

28. Стукалова О.В., Миронова Н.А., Уцумуева М.Д., Каштанова С.Ю., Буторова Е.А., Шитов В.Н., Тарасовский Г.С., Голицын С.П., Терновой С.К. Эффективность сердечной ресинхронизирующей терапии у пациентов с хронической сердечной недостаточностью различной этиологии в зависимости от структурного поражения миокарда по данным магнитнорезонансной томографии сердца с контрастированием. Российский кардиологический журнал. 2019;24(12):22-32. https://doi.org/10.15829/1560-4071-2019-12-22-32 [Stukalova O.V., Mironova N.A., Utsumueva M.D., Kashtanova S.Yu., Butorova E.A., Shitov V.N., Tarasovsky G.S., Golitsyn S.P., Ternovoy S.K. The effectiveness of cardiac resynchronization therapy in patients with chronic heart failure of various origin depending on the structural myocardial injury in cardiac magnetic resonance imaging. Russian Journal of Cardiology. 2019;(12):22-32. (In Russ.) https://doi.org/10.15829/1560-4071-2019-12-22-32 ]

29. Coraducci F, De Zan G, Fedele D, Costantini P, Guaricci AI, Pavon AG, Teske A, Cramer MJ, Broekhuizen L, Van Osch D, Danad I, Velthuis B, Suchá D, van der Bilt I, Pizzi C, Russo AD, Oerlemans M, van Laake LW, van der Harst P, Guglielmo M. Cardiac magnetic resonance in advanced heart failure. Echocardiography. 2024 Jun;41(6):e15849. doi: 10.1111/echo.15849. PMID:38837443.